Schedule 13G ownership disclosure
Biohaven Pharmaceutical Holding Co Ltd.
Security class unavailable
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,524,951
- Percent of class
- 5.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000834237-21-006933
- Form type
- SC 13G
- Filer
- Biohaven Pharmaceutical Holding Co Ltd.
- CIK
- CIK 1689813
- Filed
- Feb 02, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership